Oppenheimer has recently resumed Allogene Therapeutics Inc (ALLO) stock to Outperform rating, as announced on August 8, 2024, according to Finviz. Earlier, on May 31, 2024, Piper Sandler had initiated ...

Investors might want to bet on Allogene Therapeutics (ALLO), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings ...

ALLO Fiber has announced construction will soon begin this spring on a network build in the city of Boulder, Colorado.

UAE-based Allo.xyz, a platform for real-world asset (RWA) tokenization and lending, has secured a $100 million Bitcoin-backed ...

Allo.xyz, a platform specializing in real-world asset (RWA) tokenization and lending, has secured a landmark $100 million ...

Addressing the $900 trillion real-world asset opportunity, Allo continues to pioneer tokenization solutions that seamlessly ...

ALLO Fiber is pleased to announce its fiber broadband network build of the City of Boulder, CO. ALLO anticipates construction ...

ALLO Fiber today announced a fiber broadband project installing a 10 Gigabit network in Flagstaff, AZ. This fiber connection ...

Allo Communications LLC, a Lincoln, Nebraska-based telecommunications company, plans to build a fiber-optic broadband network ...

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lowered its holdings in shares of Allogene Therapeutics, ...

The allogeneic bone marrow-derived mesenchymal stromal cell (MSC) therapy Ryoncil (remestemcel-L-rknd) has been approved for ...